The PROSPER trial.
Stefanec
Tihomir
T
D000367:Age Factors; D000368:Aged; D000375:Aging / Q000502:physiology; D000924:Anticholesteremic Agents / Q000009:adverse effects*; D016228:Endothelial Growth Factors / Q000502:physiology; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000502:physiology; D008222:Lymphokines / Q000187:drug effects / Q000502:physiology; D009369:Neoplasms / Q000139:chemically induced*; D009389:Neovascularization, Pathologic / Q000139:chemically induced / Q000209:etiology; D017035:Pravastatin / Q000009:adverse effects*; D011237:Predictive Value of Tests; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000924:Anticholesteremic Agents; D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D017035:Pravastatin